NASDAQ Biotechnology Index (NBI) Companies by Market Cap

The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.67 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.

Total Market Cap (USD)

$1.67 Trillion

Constituent Companies

263

Index Country

USA
Rank Company Weight (%) Market Cap (USD) Sector Industry Price 24h Change
251 Applied Therapeutics Inc
NASDAQ:APLT
% $14.86 Million Healthcare Biotechnology $0.10 +0.00%
252
Grifols SA ADR
NASDAQ:GRFS
% - Healthcare Drug Manufacturers - General - -
253
Sanofi ADR
NASDAQ:SNY
% - Healthcare Drug Manufacturers - General - -
254
BeiGene Ltd
NASDAQ:BGNE
% - Healthcare Biotechnology - -
255
HUTCHMED DRC
NASDAQ:HCM
% - Healthcare Drug Manufacturers - Specialty & Generic - -
256
Mind Medicine Inc
NASDAQ:MNMD
% - Healthcare Biotechnology - -
257
BioNTech SE
NASDAQ:BNTX
% - Healthcare Biotechnology - -
258
CureVac NV
NASDAQ:CVAC
% - Healthcare Biotechnology - -
259
Eliem Therapeutics Inc
NASDAQ:ELYM
% - Healthcare Biotechnology - -
260
Alvotech
NASDAQ:ALVO
% - Healthcare Drug Manufacturers - Specialty & Generic - -
261
ARCA Biopharma Inc
US:ABIO
% - Healthcare Biotechnology - -
262
AVROBIO Inc
US:AVRO
% - Healthcare Biotechnology - -
263
Reneo Pharmaceuticals Inc
US:RPHM
% - Healthcare Biotechnology - -

Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices